Stockreport

Cogent Biosciences (COGT) Is Up 13.1% After FDA RTOR Nod For Bezuclastinib Combo - Has The Bull Case Changed? [Yahoo! Finance]

Cogent Biosciences, Inc.  (COGT) 
Last cogent biosciences, inc. earnings: 11/8 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.cogint.com/investor-relations
PDF imatinib-treated Gastrointestinal Stromal Tumor patients under the Real-Time Oncology Review program, following Phase 3 data showing improved progression-free survival a [Read more]